Keeping Track: FDA Approval Activity Heats Up With Ocaliva, Zinbryta And More
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Keeping Track: Approval Of First Intranasal Naloxone Copycat Highlights Otherwise Generic Week
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: Rebuff Of Iclaprim Creates Early Pileup Of CRLs For Novel Drugs
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: FDA Clears Motegrity And Second Herceptin Biosimilar, But Rebuffs SpecGx's Oxycodone
The latest drug development news and highlights from our US FDA Performance Tracker.